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We  present  an  electrode  based  on complementary  metal  oxide  semiconductor  (CMOS)  technology  that
can  be  made  fully  biocompatible  and  chemically  inert  using  a  simple,  low-cost  and  non-specialised
process.  Since  these  devices  are  based  on ubiquitous  CMOS  technology,  the  integrated  circuits  can  be
readily  developed  to include  appropriate  ampliﬁers,  ﬁlters  and  wireless  subsystems,  thus  reducing  the
complexity  and  cost  of  external  systems.  The  unprocessed  CMOS  aluminium  electrodes  are  modiﬁed
using  anodisation  and  plating  techniques  which  do not  require  intricate  and  expensive  semiconduc-
tor  processing  equipment  and  can  be performed  on  the  bench-top  as  a clean-room  environment  is  notiosensor
euron
nodic aluminium oxide (AAO)
orous anodic aluminium (PAA)
nodisation
required.  The  resulting  transducers  are  able  to detect  both  the  fast  electrical  activity  of  neurons  and  the
slow changes  in  impedance  of  growing  and  dividing  cells.  By  using  standard  semiconductor  fabrication
techniques  and  well-established  technologies,  the  approach  can form  the  basis  of  cell-based  biosensors
and  transducers  for  high  throughput  drug  discovery  assays,  neuroprosthetics  and  as  a  basic  research
tool  in  biosciences.  The  technology  is  equally  applicable  to  other  biosensors  that  require  noble  metal  or
nanoporous  microelectrodes.. Introduction
The direct interfacing of semiconductor technology to live,
xcitable biological tissue was initially demonstrated in the late
0th century (Fromherz et al., 1991) and has continued to be of sig-
iﬁcant interest for applications such as bidirectional stimulation
nd recording systems (Supplementary Information Table S1), high
ontent screening or implantable electronic devices. The electrical
nterface between biological tissue and semiconductor electronics
s a vital component of a successfully functioning system and often
akes the form of a low impedance electrode (Graham et al., 2011a;
ierlemann et al., 2011). The electrode area of the semiconductor
ie must be both biocompatible and chemically inert which has led
o the use of existing manufacturing methods requiring specialist
nd expensive device manufacture. This has limited their appli-
ation in key areas such as high-throughput screening and drug
iscovery.
This article presents an economical, ﬂexible and biocompat-ble bio-sensing device based on standard CMOS technology in
hich aluminium electrodes are modiﬁed using simple anodisation
nd plating techniques. The modiﬁcation process does not require
∗ Corresponding author. Tel.: +44 1225 836071.
E-mail address: abmahdg@agraham.me.uk (A.H.D. Graham).
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intricate and expensive semiconductor post-processing equipment
and can be performed with simple bench-top equipment. A clean-
room environment is not required. This new approach provides the
basis for low-cost mass-manufacture of electrodes. We  demon-
strate that the modiﬁed CMOS is readily conﬁgured for neuron
action potential recordings and cell-substrate impedance systems
and such an approach can be used in many other applications such
as DNA hybridisation (electrophoresis) (Liu et al., 2006) and DNA
sequencing (Ion Torrent Systems Inc., 2010). Individual microelec-
trodes are addressable using on-chip circuits and can meet the
requirements for long-term and non-invasive cell culture assays
and label-free high content screening.
2. Materials and methods
2.1. CMOS device construction
The CMOS integrated circuits (ICs) comprised of 48 elec-
trodes for recording extracellular action potential activity in adult
mammalian neurons and for sensing the electric cell-substrate
impedance (ECIS) of an epithelial cell line.
Open access under CC BY license.The CMOS ICs were fabricated by austriamicrosystems AG,
Germany using 0.8 m technology. Thirty devices were supplied
in 48-pin ceramic dual in line (DIL) packages with removable die-
cavity lids. A further 18 bare dice were partially encapsulated
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2Fig. 1. The CMOS device and electrode layo
y Quik-Pak (San Diego, U.S.) using their standard manufactur-
ng process, except that biocompatible compounds were speciﬁed,
amely: Silastic Medical Adhesive Silicone Type A (Dow Corning,
.S.) for placement of the window frame and Hysol CB064 (Loc-
ite, U.S.) for encapsulation (Graham et al., 2011b).  A cyanoacrylate
dhesive was used for a permanent bond, or the glass adhered using
ilastic 9161 (Dow Corning, UK) so that the packages could be more
asily disassembled, e.g. for scanning electron microscopy analysis.
Glass cylinders, 10 mm tall, 13 mm internal diameter (QB Glass,
K), were adhered to the upper surface of the packages encircling
he open die cavities so that the 48 electrodes were exposed at the
ase of each chamber. These formed receptacles for further process-
ng of the electrodes and subsequently functioned as cell culture
hambers (Fig. 1).
To interface the CMOS technology directly with biological tis-
ue, while maintaining biocompatibility and chemical inertness
he aluminium electrodes were anodised to form nano-porous
lumina (aluminium oxide). The nano-pores were subsequently
nﬁltrated with gold and plated (Graham et al., 2009a,b, 2010)
ith platinum black to reduce and optimise the electrode electri-
al impedance for neuronal recordings (Fig. 2). This economic and
imple CMOS modiﬁcation process begins with anodisation of the
luminium electrodes for approximately 40 min in 0.4 M phospho-
ic acid, followed by 20 min  plating of the anodised nano-porous
lumina in 59 mM gold chloride (HAuCl43H2O) and approximately
ig. 2. Scanning electron microscope (SEM) image of a single electrode with section
reated by milling with a focused ion beam (FIB). The inner circular area is the elec-
rode (30 m diameter). This is surrounded by approximately 10 m of aluminium
hich appears as an outer ‘ring’ which is connected to the aluminium track leading
ff  to the left. The inset shows the porous alumina ﬁlled with gold. Inset scale bar
00 nm.e silicon dimensions are 3.1 mm ×3.1 mm.
one minute for platinum black deposition using chloroplatinic acid
(H2PtC166H2O) with 264 M Lead(II) acetate trihydrate. Fig. 2 (sup-
ported by Supplementary Fig. S1)  shows a section of an electrode
processed using this method, illustrating the uniform anodisation
and gold deposition across the area of the electrode. Full details
of the method were presented in Graham et al. (2010).  The net
result of this process is that the CMOS aluminium electrode, which
normally corrodes when in contact with a saline culture medium,
is converted to a chemically inert, low impedance electrode con-
sisting of aluminium oxide, gold and high surface area platinum
black.
2.2. Cell culture
Rat dorsal root ganglion cells were cultured as previously
described (England et al., 2001). In brief, adult (250 g) Sprague-
Dawley rats were housed and killed according to UK Home Ofﬁce
regulations. The dorsal root ganglia were dissected into Ham’s
F14 media supplemented with penicillin (100 IU ml−1 Sigma, UK),
streptomycin (100 g ml−1, Sigma) l-glutamine (2 mM,  Sigma) and
10% foetal calf serum (FCS, Invitrogen, UK). The ganglia were trans-
ferred to F14 medium containing 0.125% collagenase and incubated
at 37 ◦C in 5% CO2 95% air for 40 min. The cells were further
transferred into F14 medium with added nerve growth factor
(50 ng ml−1) and plated on the sterile CMOS devices which had been
previously coated with poly-l-lysine (15–30 kDa, 0.01%, w/v). The
devices were then kept at 37 ◦C in 5% CO2/95% air for 18–24 h.
The Caco-2 human epithelial cell line was  chosen for the ECIS
recordings as the cells continually divide to produce a monolayer
(Hidalgo et al., 1989). Cells were cultured in DMEM/F-12 media
supplemented with l-glutamine (1%, w/v, Sigma), FCS (10%, w/v)
and non-essential amino acids (1%, w/v). Cells were grown in 50 ml
ﬂasks (Nunc, UK) to 90–100% conﬂuency at 5% CO2 and 37 ◦C. The
cells were dissociated from the ﬂasks by 3–6 min  trypsinsation
(0.5%, w/v, Worthington) after having been rinsed in EDTA (10 mM,
Sigma, UK) and calcium and magnesium free phosphate buffered
saline. Detached cells were spun down (5 min at 700 rpm), re-
suspended in fresh medium and plated onto the sterilised (ethanol
30 min) devices.
2.3. Electrophysiological recording
To demonstrate that the simply modiﬁed CMOS can sense the
fast electrical activity of neurons, primary cultures of rat dorsal
root ganglion (DRG) cells (England et al., 2001) were plated onto
poly-lysine coated CMOS devices that were incubated for 18 h, as
described in the previous section. Recordings were undertaken
at 21 ◦C by placing the CMOS devices in a 48-pin zero insertion
4  and Bioelectronics 31 (2012) 458– 462
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Fig. 3. Extracellular spontaneous action potentials (spikes) recorded from a DRG
sampled at 25 kHz (bandwidth 1–5000 Hz). The frequency of the neuron activity,
measured over a 20 s epoch, was 14.7 ± 0.1 Hz (mean ± SEM, n = 20) and the signal to
noise ratio was  approximately 5:1. The inset shows one of the spikes on an expanded
time axis.
Fig. 4. The potent and selective sodium channel blocker, tetrodotoxin, reversibly
inhibits spontaneous action potential activity. Spike frequency plotted in 1 s epochs
before, during (black bar) and after the application of 100 nM tetrodotoxin (TTX).
The gap in the horizontal axis is 900 s. Spike frequency is measured as ‘spikes per
second’ – Hertz.60 A.H.D. Graham et al. / Biosensors
orce (ZIF) socket connected to a 64 channel preampliﬁer (PAG64,
ultichannel Systems) which was housed in a Faraday cage. The
reampliﬁer was connected to an MC  card (Multichannel Systems)
ocated in a PC (generic) running MC  Rack software (v 3.1, Mul-
ichannel Systems). The sample rate was 25 kHz per channel and
he recording bandwidth was 1 Hz to 5 kHz. Spontaneous activity
as continually recorded onto a hard disk, initially in the culture
edium and then in a modiﬁed Kreb’s solution (mM):  NaCl (130),
Cl (3), MgCl2 (1), CaCl2 (1), HEPES (5), Glucose (11), pH adjusted to
.4 using 2 M NaOH. Tetrodotoxin (100 nM,  TTX, Tocris, UK), Adeno-
ine triphosphate (100 M,  ATP, Sigma, UK) and KCl (12 mM)  were
pplied via the superfusion system at 21 ◦C ﬂowing at 2.3 ml  min−1.
.4. Electric cell-substrate impedance sensing recordings
The ability of the CMOS device to function as an electric
ell-substrate impedance sensor and monitor the real-time elec-
rical impedance changes associated with cell growth and division
Hidalgo et al., 1989; Prakash & Abshire, 2008) was assessed using
he Caco-2 cell line.
CMOS devices were placed in an incubator (5% CO2/95% air,
7 ◦C) mounted in a 48-pin ZIF socket. The 48 electrodes on a
MOS device were connected together as the active electrode and
 reference electrode (Ag/AgCl wire) was placed in the culture
edia bathing the cells. Impedance was measured using a preci-
ion impedance analyser (Agilent 4294A) at the frequency range
0 Hz to 1 MHz. Samples were taken every 15 s for the ﬁrst 15 min
hen every 1 min  for a further 45 min  and ﬁnally every 60 min  for up
o 5 days. Control devices with no cells showed impedance changes
ver the same period of less than 200 .
.5. Data analysis
For the electrophysiological recordings, data stored on the hard
isk were converted to pClamp ABF ﬁles by MCDataTool (Multi-
hannel Systems) and spike frequency and fast Fourier analysis data
ere generated using the pClamp (v8.2, Axon Instruments, USA)
rogram suite. For the ECIS experiments, the imaginary impedance
′′ was calculated using the equation Z′′ = 1/(2fC), where C is the
apacitance, f the signal frequency (47.9 kHz) and Z the complex
mpedance. Statistical analysis was performed using ANOVA with
 < 0.05 considered signiﬁcant.
. Results
.1. Neuronal recordings
Fig. 3 shows successful recordings of action potentials initially
erformed in the culture medium and the inset shows an individ-
al spiking event. The spontaneous activity of a cell, measured over
 20 s epoch, was 14.7 ± 0.1 Hz (mean ± SEM, n = 20). The signal
o noise ratio was approximately 5:1 and power spectral anal-
sis of the noise showed no unexpected peaks (Supplementary
nformation Fig. S2).
On superfusion with a buffer solution the ﬁring frequency was
7.4 ± 0.1 Hz (n = 20). In order to conﬁrm that the fast spiking
ctivity was generated by action potentials of neurons they were
uccessfully blocked in a selective and reversible manner by 100 nM
etrodotoxin, a potent selective sodium channel blocker (Fig. 4).
ig. 5 shows that an increase in extracellular potassium from 3 mM
o 15 mM to depolarise the cells (by ∼40 mV,  predicted from the
ernst equation) also led to a reversible and signiﬁcant (p < 0.01)
ncrease in neuron ﬁring rate. Similarly, the application of 100 M
denosine triphosphate, an excitatory neurotransmitter, also sig-
iﬁcantly (p < 0.01) increased the activity of the cell.
Fig. 5. DRG excitability can be increased by extracellular potassium and neurotrans-
mitters. (a) Mean (±SEM, 15 × 1 s epochs) spike frequency before (‘cont’), during
(‘KCl’) an after (‘wash’) an increase in [K+]o (3–15 mM)  and (b) before (‘cont’), during
(‘ATP’) and after (‘wash’) application of 100 M adenosine triphosphate.
A.H.D. Graham et al. / Biosensors and B
Fig. 6. Cell growth can be measured by impedance changes. Mean imaginary
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Umpedance, Z′′ (measured at 47.9 kHz at 37 ◦C) over 2.7 days. (i) 4 devices containing
aco-2 cells and (ii) 3 devices containing the same culture medium but no cells. Only
ositive error bars (SEM) are shown for clarity.
.2. ECIS recordings
Fig. 6 illustrates the measured increase in electrical impedance
ith time as the cells form a monolayer over the modiﬁed elec-
rodes, compared to CMOS devices under identical conditions but
ontaining no cells.
. Discussion
The neuronal recording results demonstrate that the simply
odiﬁed CMOS device is able to record non-invasively both the
pontaneous and evoked extracellular action potentials of mam-
alian neurons over a period of hours. Therefore, the device can
e used to monitor the excitability changes in cells in response to
oth physiological and pharmacological interventions. In view of
he stability of the device (see Fig. 6), long-term monitoring of activ-
ty is possible for many days, probably weeks, making it suitable
or in vitro investigations into drug dependence, complex network
ctivity, neurodegereration and neuronal development.
The ECIS results illustrate the ﬂexibility of the modiﬁed CMOS
echnology. In this conﬁguration, the electrode array can be used to
tudy tumour growth, wound healing, cell migration and for under-
tanding how cells interact with a substrate (Bionas GmbH, 2010).
 model is presented in Wegener et al. (2000) which shows an
lmost linear relationship between capacitance and the fraction
f electrode surface covered by cells: with 1.0 being the nor-
alised capacitance of an uncovered electrode and 0.3 being the
ormalised capacitance with cells completely covering an elec-
rode. The capacitance, C, is derived simply from the impedance
esults using C = 1/(2fZ′′), as explained in Section 2.5. Transform-
ng the data of Fig. 6 in this manner (Supplementary Information
ig. S3)  shows the capacitance for a single IC with Caco-2 cells
xhibited a reduction in normalised capacitance from 1.0 to 0.4.
sing the linear relationship, this represents electrode coverageioelectronics 31 (2012) 458– 462 461
of 86%. It is also noted that the capacitance stabilised at 3 days
which is probably indicative of the cells becoming conﬂuent. These
results are therefore in broad agreement with the model. Unfortu-
nately, it was not possible to correlate electrical results with images
of the electrode array since the epi-illuminated microscope used
in this work was incapable of imaging the ﬂattened monolayer
(the cells appearing transparent). This ECIS experiment therefore
demonstrates the ability of the low-cost post-processed CMOS IC
technology to function as an impedance sensor. Reversibility of the
impedance changes by cleaning of the arrays indicated that the
measured effects were due to cell growth rather than damage to
the device, for example corrosion. This is further supported by the
fact that controls were run with the media but no cells, so if corro-
sion was occurring, it would have resulted in Z′′ changes in these
devices also, but no such effect was observed. Furthermore, re-use
of the ICs demonstrates the corrosion resistance of the modiﬁed
electrodes and the stability of the IC packaging to at least 40 days.
As an economic method of forming generic biocompatible CMOS
electrodes, the process is not limited to cell-based biosensors and
can be used to form transducers in many other types of elec-
trochemical biosensor. Potential applications therefore include
medical diagnosis and monitoring (e.g. wound healing), medi-
cal implants (e.g. glucose monitoring), environmental monitoring,
detecting pathogens in food and water and for defence through the
detection of biological agents (Velusamy et al., 2010).
Further work is in progress to demonstrate that the anodis-
ing and post-processing can be performed via on-chip circuits. It
is intended that anodisation is performed with zero silicon area
overhead by using only the standard electrostatic discharge (ESD)
protection circuits that must be present in any commercial (high
yield and reliable) CMOS device. Additionally, the authors will
assess the technology as a biosensor of harmful biologic agents (e.g.
saxitoxin): this will evaluate open porous alumina electrodes and
porous alumina ﬁlled with gold, but with a smooth surface more
suited to sensing antigen binding. With regards to commercialisa-
tion, initial products are likely to require the post-processing to be
performed after packaging, as in this work. This requires anodisa-
tion and plating counter electrode conﬁgurations that are speciﬁc
to the packaging. A preferred approach is therefore to post-process
the devices at the wafer-level, prior to application-speciﬁc assem-
bly. This would require a low-resolution (millimetre scale) mask,
but would still not require complex lithography or a clean-room
environment. This approach would, however, require biasing of
the wafers during post-processing and therefore requires further
research to assess its feasibility. Wafer-level processing would aid
suitability of this technology for applications requiring no IC wire-
bonds, such as monolithic wireless devices utilising radio frequency
identiﬁcation (RFID) and medical implants.
5. Conclusion
A simple method has been established by which aluminium
electrodes realised in standard CMOS technology can be made bio-
compatible and sense both the fast electrical activity of neurons
and the slow changes in impedance of growing and dividing cells.
Since the devices are based on ubiquitous CMOS technology the
integrated circuits can be readily developed, with minimal addi-
tional fabrication costs, to include appropriate ampliﬁers, ﬁlters
and wireless subsystems, thus reducing the complexity and cost
of the external recording system. By using standard semiconduc-
tor fabrication techniques and well-established technologies, such
devices can form the basis of a wide range of applications includ-
ing single-use (disposable) biosensors in high throughput drug
discovery assays, neuroprosthetics and as a basic research tool in
biosciences.
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